ATG101

Across TCGA pan-cancer cohorts, ATG101 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ATG101’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where ATG101 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ATG101 is over-expressed in tumor.

CCRCC, LSCC, and PDAC are the cancer types where ATG101 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATG101 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	All	IV	+0.302	<.001	12	view →
LSCC	Male	All	+0.129	<.001	4	view →
PDAC	All	All	+0.428	.004	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ATG101–CCRCC

Open the CCRCC breakdown →